Researchers have already discovered compounds, radioprotective characteristics of which, at lower toxicity, exceed all compounds known so far. However, investigations have not been finished yet. The search for new radioprotectors (effective, innocuous and low-cost ones), as well as compounds that increase radio-therapy efficiency for cancer treatment, is going on. Information about this very important development was placed by the ISTC experts on the International Science and Technology Center’s site, in the advanced research section.
Generally, many countries of the world are searching compounds that are able to protect human beings and animals from ionizing radiation. However, the results of this effort remain pretty moderate. Known substances that are potentially suitable for practical use are few and none of them meets all requirements to drugs.
“Even the most efficient radioprotectors from well-known ones, - explains project manager, I. Korzeneva, Ph.D. (Biology), - for example, cystamine (the substance used for treatment of acute radiation sickness) either did not protect sufficiently from exposure to radiation or were too toxic. Besides, in the majority of cases, these drugs possess prophylactic (introduction prior to irradiation), but not therapeutic (introduction after irradiation) action. We suggest that the range of compounds should be extended, among which we hope to find not only efficient radioprotectors with prophylactic, therapeutic and immunomodulatory action, but also radiation sensitizers reinforcing ionizing radiation of tumor cells. We expect that new drugs will possess high bioavailability and low toxicity, and it will be possible to perform their synthesis based on domestic raw materials, and this will tell upon cost.”
It should be noted that researchers’ assurance is fully justified. Now, the authors have already managed to synthesize compounds, radioprotective properties of which are much higher than those of cystamine, active leucostimulators and antineoplastic drugs. Experiments have proved that these substances protect from death irradiated laboratory animals or extend their lifetime. Besides, the researchers have synthesized new immunomodulators, antioxidants and antihypoxic agents, which are similar or more efficient as compared to the known ones.
The researchers’ short-term plans are as follows: to discover several most promising drugs and to develop quick, efficient, low-stage and low-cost methods of their synthesis. It is also necessary to make the required amount of drugs for preclinical trials. To minimize time and effort spent on search of new compounds with predetermined properties, the authors are planning to engage computer simulation techniques.
Thus, in case of proper funding, drugs for protection of staff of nuclear power-stations, radioactive waste processing enterprises, and eventually, cosmonauts, will be not only developed but also synthesized likewise drugs for radio-therapy of oncological diseases, which are able to fight against malignant cells without injuring healthy cells.
Nadezda Markina | alfa
Staying in Shape
16.08.2018 | Max-Planck-Institut für molekulare Zellbiologie und Genetik
Chips, light and coding moves the front line in beating bacteria
16.08.2018 | Okinawa Institute of Science and Technology (OIST) Graduate University
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur
What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...
08.08.2018 | Event News
27.07.2018 | Event News
25.07.2018 | Event News
16.08.2018 | Life Sciences
16.08.2018 | Earth Sciences
16.08.2018 | Life Sciences